161 related articles for article (PubMed ID: 34911343)
1. Association of
Walia HK; Singh N; Sharma S
Pharmacogenomics; 2022 Jan; 23(2):97-118. PubMed ID: 34911343
[No Abstract] [Full Text] [Related]
2. N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia.
Kamel AM; Ebid GT; Moussa HS
Tumour Biol; 2015 Aug; 36(8):6341-8. PubMed ID: 25804798
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in the
Walia HK; Singh N; Sharma S
Future Oncol; 2021 Dec; 17(35):4925-4946. PubMed ID: 34672683
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis.
Ben Mahmoud L; Ghozzi H; Kamoun A; Hakim A; Hachicha H; Hammami S; Sahnoun Z; Zalila N; Makni H; Zeghal K
Pathol Biol (Paris); 2012 Oct; 60(5):324-30. PubMed ID: 21856096
[TBL] [Abstract][Full Text] [Related]
5. N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients.
Borlak J; Reamon-Buettner SM
BMC Med Genet; 2006 Jul; 7():58. PubMed ID: 16827944
[TBL] [Abstract][Full Text] [Related]
6. N-Acetyltransferase-2 (NAT2) gene polymorphisms and enzyme activity in Serbs: unprecedented high prevalence of rapid acetylators in a White population.
Djordjevic N; Carrillo JA; Ueda N; Gervasini G; Fukasawa T; Suda A; Jankovic S; Aklillu E
J Clin Pharmacol; 2011 Jul; 51(7):994-1003. PubMed ID: 20801937
[TBL] [Abstract][Full Text] [Related]
7. Association of
Singh S; Singh N; Baranwal M; Sharma S
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147951
[TBL] [Abstract][Full Text] [Related]
8. Study on Genotyping Polymorphism and Sequencing of N-Acetyltransferase 2 (NAT2) among Al-Ahsa Population.
Zahra MA; Kandeel M; Aldossary SA; Al-Taher A
Biomed Res Int; 2020; 2020():8765347. PubMed ID: 32626768
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes.
Hein DW; Doll MA
Pharmacogenomics; 2012 Jan; 13(1):31-41. PubMed ID: 22092036
[TBL] [Abstract][Full Text] [Related]
10. [Role of gene polymorphisms of phase II of xenobiotic biotransformation from glutathione-S-transferase and N-acetyltransferase families in susceptibility to lung cancer among Mayak workers].
Rusinova GG; Azizova TV; Viazovskaia NS; Glazkova IV; Gur'ianov MIu; Osovets SV
Radiats Biol Radioecol; 2014; 54(4):350-9. PubMed ID: 25775823
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Genetic Polymorphisms of N-acetyltransferase 2 and Relation with Chronic Myeloid Leukemia.
Tebien EM; Khalil HB; Mills J; Elderdery AY
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3711-3717. PubMed ID: 33369472
[TBL] [Abstract][Full Text] [Related]
12. Arylamine N-acetyltransferase (NAT2) genotypes in Africans: the identification of a new allele with nucleotide changes 481C>T and 590G>A.
Dandara C; Masimirembwa CM; Magimba A; Kaaya S; Sayi J; Sommers DK; Snyman JR; Hasler JA
Pharmacogenetics; 2003 Jan; 13(1):55-8. PubMed ID: 12544513
[TBL] [Abstract][Full Text] [Related]
13. Expression of NAT2 in immune system cells and the relation of NAT2 gene polymorphisms in the anti-tuberculosis therapy in Mexican mestizo population.
Salazar-González R; Gómez R; Romano-Moreno S; Medellín-Garibay S; Núñez-Ruíz A; Magaña-Aquino M; Milán-Segovia RC; Portales-Pérez DP
Mol Biol Rep; 2014 Dec; 41(12):7833-43. PubMed ID: 25163630
[TBL] [Abstract][Full Text] [Related]
14. N-acetyltransferase 2 enzyme genotype-phenotype discordances in both HIV-negative and HIV-positive Nigerians.
Kotila OA; Fawole OI; Olopade OI; Ayede AI; Falusi AG; Babalola CP
Pharmacogenet Genomics; 2019 Jul; 29(5):106-113. PubMed ID: 30882558
[TBL] [Abstract][Full Text] [Related]
15. N-acetyltransferase 2 (NAT2) gene polymorphisms in Parkinson's disease.
Borlak J; Reamon-Buettner SM
BMC Med Genet; 2006 Mar; 7():30. PubMed ID: 16571112
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in NAT2 (N-acetyltransferase 2) gene in patients with systemic lupus erythematosus.
Santos EC; Pinto AC; Klumb EM; Macedo JM
Rev Bras Reumatol Engl Ed; 2016; 56(6):521-529. PubMed ID: 27914600
[TBL] [Abstract][Full Text] [Related]
17.
Mthiyane T; Millard J; Adamson J; Balakrishna Y; Connolly C; Owen A; Rustomjee R; Dheda K; McIlleron H; Pym AS
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964788
[TBL] [Abstract][Full Text] [Related]
18. Association of
Walia HK; Singh N; Sharma S
Per Med; 2021 Jul; 18(4):333-346. PubMed ID: 33973803
[No Abstract] [Full Text] [Related]
19. [Association of NAT2 polymorphism with risks to develop psoriasis and various dermatological diseases in Moscow population].
Kozhekbaeva ZhM; Gra OA; Fadeev VS; Goldenkova-Pavlova IV; Korsunskaia IM; Bruskin SA; Agafonova EE; Piruzian AL; Surzhikov SA; Nasedkina TV
Mol Biol (Mosk); 2009; 43(1):62-76. PubMed ID: 19334527
[TBL] [Abstract][Full Text] [Related]
20. Genetic Variants in the Wingless Antagonist Genes (
Bahl C; Singh N; Behera D; Sharma S
Cancer Biother Radiopharm; 2018 Dec; 33(10):466-477. PubMed ID: 30346805
[No Abstract] [Full Text] [Related]
[Next] [New Search]
